nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.522	1	CbGbCtD
Ganciclovir—SLC22A7—Organic anion transport—SLC22A12—nephrolithiasis	0.0357	0.151	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic anion transport—SLC22A12—nephrolithiasis	0.03	0.127	CbGpPWpGaD
Ganciclovir—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0251	0.106	CbGpPWpGaD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0166	0.0704	CbGpPWpGaD
Ganciclovir—SLC22A8—nephron—nephrolithiasis	0.0153	0.214	CbGeAlD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.014	0.0592	CbGpPWpGaD
Ganciclovir—SLC22A8—urine—nephrolithiasis	0.0123	0.172	CbGeAlD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0117	0.0494	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00907	0.0384	CbGpPWpGaD
Ganciclovir—SLC22A6—nephron tubule—nephrolithiasis	0.00553	0.0773	CbGeAlD
Ganciclovir—SLC22A7—renal system—nephrolithiasis	0.0052	0.0728	CbGeAlD
Ganciclovir—SLC22A7—kidney—nephrolithiasis	0.00503	0.0704	CbGeAlD
Ganciclovir—SLC22A7—cortex of kidney—nephrolithiasis	0.0049	0.0685	CbGeAlD
Ganciclovir—SLC22A6—cortex of kidney—nephrolithiasis	0.00473	0.0662	CbGeAlD
Ganciclovir—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0239	CcSEcCtD
Ganciclovir—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00381	0.0223	CcSEcCtD
Ganciclovir—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00355	0.0208	CcSEcCtD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00333	0.0141	CbGpPWpGaD
Ganciclovir—SLC22A8—nephron tubule—nephrolithiasis	0.00331	0.0463	CbGeAlD
Ganciclovir—SLC22A1—renal system—nephrolithiasis	0.00327	0.0458	CbGeAlD
Ganciclovir—SLC22A1—kidney—nephrolithiasis	0.00316	0.0442	CbGeAlD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0031	0.0131	CbGpPWpGaD
Ganciclovir—SLC22A8—renal system—nephrolithiasis	0.00301	0.0421	CbGeAlD
Ganciclovir—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0175	CcSEcCtD
Ganciclovir—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00297	0.0174	CcSEcCtD
Ganciclovir—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00293	0.0171	CcSEcCtD
Ganciclovir—SLC22A8—kidney—nephrolithiasis	0.00291	0.0407	CbGeAlD
Ganciclovir—SLC22A8—cortex of kidney—nephrolithiasis	0.00283	0.0396	CbGeAlD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0028	0.0119	CbGpPWpGaD
Ganciclovir—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00274	0.016	CcSEcCtD
Ganciclovir—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00269	0.0157	CcSEcCtD
Ganciclovir—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00262	0.0154	CcSEcCtD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0026	0.011	CbGpPWpGaD
Ganciclovir—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00258	0.0151	CcSEcCtD
Ganciclovir—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00248	0.0145	CcSEcCtD
Ganciclovir—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00246	0.0144	CcSEcCtD
Ganciclovir—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0024	0.014	CcSEcCtD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00234	0.0099	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00218	0.00925	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00217	0.0092	CbGpPWpGaD
Ganciclovir—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0124	CcSEcCtD
Ganciclovir—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00205	0.012	CcSEcCtD
Ganciclovir—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00202	0.0118	CcSEcCtD
Ganciclovir—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.002	0.0117	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.002	0.00846	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.002	0.00846	CbGpPWpGaD
Ganciclovir—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00196	0.0115	CcSEcCtD
Ganciclovir—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0112	CcSEcCtD
Ganciclovir—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0112	CcSEcCtD
Ganciclovir—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0112	CcSEcCtD
Ganciclovir—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00189	0.0111	CcSEcCtD
Ganciclovir—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00188	0.011	CcSEcCtD
Ganciclovir—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00188	0.011	CcSEcCtD
Ganciclovir—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00184	0.0108	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00184	0.00778	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00182	0.00769	CbGpPWpGaD
Ganciclovir—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0018	0.0106	CcSEcCtD
Ganciclovir—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0105	CcSEcCtD
Ganciclovir—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00178	0.0105	CcSEcCtD
Ganciclovir—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00176	0.0103	CcSEcCtD
Ganciclovir—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00175	0.0102	CcSEcCtD
Ganciclovir—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0102	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00172	0.01	CcSEcCtD
Ganciclovir—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00172	0.01	CcSEcCtD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00169	0.00715	CbGpPWpGaD
Ganciclovir—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00987	CcSEcCtD
Ganciclovir—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00984	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00984	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00168	0.00711	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00168	0.00711	CbGpPWpGaD
Ganciclovir—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00971	CcSEcCtD
Ganciclovir—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00964	CcSEcCtD
Ganciclovir—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00945	CcSEcCtD
Ganciclovir—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00902	CcSEcCtD
Ganciclovir—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00902	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00153	0.00649	CbGpPWpGaD
Ganciclovir—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00896	CcSEcCtD
Ganciclovir—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00891	CcSEcCtD
Ganciclovir—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00888	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00151	0.00641	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00151	0.00641	CbGpPWpGaD
Ganciclovir—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0015	0.0088	CcSEcCtD
Ganciclovir—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00149	0.0087	CcSEcCtD
Ganciclovir—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00865	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00852	CcSEcCtD
Ganciclovir—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00845	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00843	CcSEcCtD
Ganciclovir—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00838	CcSEcCtD
Ganciclovir—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00836	CcSEcCtD
Ganciclovir—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00836	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00141	0.00596	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00141	0.00596	CbGpPWpGaD
Ganciclovir—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00824	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0014	0.00594	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0014	0.00594	CbGpPWpGaD
Ganciclovir—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0082	CcSEcCtD
Ganciclovir—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00802	CcSEcCtD
Ganciclovir—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00774	CcSEcCtD
Ganciclovir—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00772	CcSEcCtD
Ganciclovir—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00768	CcSEcCtD
Ganciclovir—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00766	CcSEcCtD
Ganciclovir—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0076	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00127	0.00539	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00127	0.00539	CbGpPWpGaD
Ganciclovir—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00744	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00125	0.00531	CbGpPWpGaD
Ganciclovir—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00125	0.0073	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00125	0.00527	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00125	0.00527	CbGpPWpGaD
Ganciclovir—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00123	0.0072	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00119	0.00504	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00118	0.00501	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00118	0.00501	CbGpPWpGaD
Ganciclovir—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00118	0.0069	CcSEcCtD
Ganciclovir—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00682	CcSEcCtD
Ganciclovir—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00662	CcSEcCtD
Ganciclovir—Tension—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00659	CcSEcCtD
Ganciclovir—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00658	CcSEcCtD
Ganciclovir—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00653	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00111	0.0047	CbGpPWpGaD
Ganciclovir—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00111	0.0065	CcSEcCtD
Ganciclovir—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00646	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00109	0.00461	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00109	0.00461	CbGpPWpGaD
Ganciclovir—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00633	CcSEcCtD
Ganciclovir—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00107	0.0063	CcSEcCtD
Ganciclovir—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00623	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00106	0.0045	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00106	0.0045	CbGpPWpGaD
Ganciclovir—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00621	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00105	0.00447	CbGpPWpGaD
Ganciclovir—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00617	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00105	0.00443	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00105	0.00443	CbGpPWpGaD
Ganciclovir—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00606	CcSEcCtD
Ganciclovir—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00604	CcSEcCtD
Ganciclovir—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00601	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00102	0.0043	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00102	0.0043	CbGpPWpGaD
Ganciclovir—Cough—Hydrochlorothiazide—nephrolithiasis	0.001	0.00586	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000988	0.00418	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000988	0.00418	CbGpPWpGaD
Ganciclovir—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000977	0.00572	CcSEcCtD
Ganciclovir—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000977	0.00572	CcSEcCtD
Ganciclovir—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000977	0.00572	CcSEcCtD
Ganciclovir—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000973	0.0057	CcSEcCtD
Ganciclovir—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000965	0.00565	CcSEcCtD
Ganciclovir—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000955	0.00559	CcSEcCtD
Ganciclovir—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000944	0.00553	CcSEcCtD
Ganciclovir—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000936	0.00548	CcSEcCtD
Ganciclovir—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000936	0.00548	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000933	0.00395	CbGpPWpGaD
Ganciclovir—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000917	0.00537	CcSEcCtD
Ganciclovir—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000914	0.00535	CcSEcCtD
Ganciclovir—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000905	0.0053	CcSEcCtD
Ganciclovir—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000892	0.00523	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00088	0.00373	CbGpPWpGaD
Ganciclovir—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000875	0.00512	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000874	0.0037	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000874	0.0037	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000853	0.00361	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000853	0.00361	CbGpPWpGaD
Ganciclovir—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000853	0.005	CcSEcCtD
Ganciclovir—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000847	0.00496	CcSEcCtD
Ganciclovir—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000841	0.00492	CcSEcCtD
Ganciclovir—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000835	0.00489	CcSEcCtD
Ganciclovir—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000832	0.00488	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000825	0.0035	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000825	0.0035	CbGpPWpGaD
Ganciclovir—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000824	0.00483	CcSEcCtD
Ganciclovir—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000814	0.00477	CcSEcCtD
Ganciclovir—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000807	0.00473	CcSEcCtD
Ganciclovir—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000801	0.00469	CcSEcCtD
Ganciclovir—Pain—Hydrochlorothiazide—nephrolithiasis	0.000801	0.00469	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000779	0.0033	CbGpPWpGaD
Ganciclovir—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000772	0.00452	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00077	0.00326	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00077	0.00326	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000767	0.00325	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000767	0.00325	CbGpPWpGaD
Ganciclovir—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000766	0.00448	CcSEcCtD
Ganciclovir—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000744	0.00436	CcSEcCtD
Ganciclovir—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00074	0.00434	CcSEcCtD
Ganciclovir—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00074	0.00434	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000715	0.00303	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000715	0.00303	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000712	0.00302	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000712	0.00302	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00069	0.00404	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000684	0.0029	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000679	0.00287	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000679	0.00287	CbGpPWpGaD
Ganciclovir—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000672	0.00393	CcSEcCtD
Ganciclovir—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000662	0.00388	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000647	0.00274	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000647	0.00274	CbGpPWpGaD
Ganciclovir—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000641	0.00375	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000638	0.0027	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000638	0.0027	CbGpPWpGaD
Ganciclovir—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000619	0.00363	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000605	0.00256	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000601	0.00255	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000601	0.00255	CbGpPWpGaD
Ganciclovir—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000595	0.00349	CcSEcCtD
Ganciclovir—Rash—Hydrochlorothiazide—nephrolithiasis	0.00059	0.00346	CcSEcCtD
Ganciclovir—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00059	0.00345	CcSEcCtD
Ganciclovir—Headache—Hydrochlorothiazide—nephrolithiasis	0.000587	0.00344	CcSEcCtD
Ganciclovir—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000556	0.00326	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000553	0.00234	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000553	0.00234	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00054	0.00229	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00054	0.00229	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000536	0.00227	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000536	0.00227	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00051	0.00216	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000502	0.00213	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000502	0.00213	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000447	0.00189	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000447	0.00189	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000428	0.00181	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000419	0.00178	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000419	0.00178	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00039	0.00165	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00039	0.00165	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000358	0.00151	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000348	0.00147	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000348	0.00147	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000278	0.00118	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000241	0.00102	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000215	0.00091	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000183	0.000773	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000183	0.000773	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.00013	0.000551	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000118	0.000498	CbGpPWpGaD
